The aim of this systematic review and meta-analysis is to assess the efficacy and safety of pramipexole compared with placebo and/or other active agents for the treatment of restless leg syndrome (RLS).
We provide solutions to compare safety and efficacy of a product and aid its approval from regulatory authorities and success in the market
Agility to grow with your needs